IRCT20190303042892N2招募中3 期
Evaluation of repeated Prescription of 177Lu-EDTMP combined with docetaxel and prednisone versus docetaxel and prednisone alone in relieving pain in patients with prostate cancer metastatic to bone. A Randomized Clinical Trial
Guilan University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- Male
入选标准
- •Patients with prostate cancer with confirmed histological evidence
- •Bone scan results confirmed metastatic bone prevelance
- •Patients enter the study in the metastatic stage
- •The absolute number of neutrophils is greater than or equal to 10^9 × 1.5 per liter
- •Platelet value greater than or equal to 10^9 × 100 per liter
- •Patients with good renal function (serum creatinine less than 150 µM / L)
- •Good liver function (total bilirubin less than or equal to 1.5 times normal
- •ALT and AST less than or equal to 2.5 times normal
排除标准
- •Patients who have already been treated with docetaxel
- •Patients who have already received 177Lu-EDTMP
研究者
相似试验
招募中
3 期
Comparison Of Low Vs High Dose 177Lu-EDTMP Therapy For Palliation Of Painful Bone Metastases: RCT.CTRI/2021/04/033060AIIMS Jodhpur
尚未招募
2 期
Effect of Lu177-dotatate in meningiomaMeningioma.Malignant neoplasm of meninges, unspecifiedC70.9IRCT20190623043986N1Shiraz University of Medical Sciences10
进行中（未招募）
2 期
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2Metastatic Castration-resistant Prostate Cancer, mCRPCNCT05579184FutureChem20
已完成
不适用
Clinical Evaluation of DP037, for contact lens usersISRCTN28788224Menicon Co. Ltd (Japan)60
尚未招募
2 期
Effectiveness of Lu177-PSMA in treatment of refractory thyroid papillary cancer.IRCT20230803059015N1Shiraz University of Medical Sciences10